Cystic Fibrosis

HCV

Tuberculosis

Cystic Fibrosis (CF) affects about 30,000 children and adults in the United States and 70,000 worldwide. Approximately 2,500 babies are born with each year, with more than 70% of CF patients diagnosed by the age of two...

Despite the challenges, there is reason for optimism in the future treatment of CF. Complications of the disease are now well understood, and a host of new therapies have emerged to help patients manage their disease...

Former U.S. Surgeon General C. Everett Koop put the hepatitis C threat this way in 1998: "We stand at the precipice of a grave threat to our public health…it affects people from all walks of life, in every state, in every country. And unless we do something about it soon, it will kill more people than AIDS." Is it that bad? In a word, yes...

HCV is a chronic disease. But unlike viruses such as HIV, hepatitis B and herpes, HCV is curable. It’s possible to completely rid the body of the virus because it never integrates itself within DNA. What the scientific and medical communities – and HCV patients – now seek is to cure more people in shorter timeframes, with more tolerable therapies...

Worldwide, tuberculosis (TB) claims an estimated 1.6 million lives each year, 4400 each day, more than any other infectious disease. The majority of TB-related deaths occur in developing countries in Africa and Southeast Asia. In 2005, 80% of new TB cases occurred in just...

Research into new and more effective strategies to control TB are advancing on multiple fronts. There is general consensus that new therapies should target shorter treatment durations and simpler combinations, both of which could lead to better compliance. To address these needs, researchers are renewing investigation of existing antibiotic classes. These new classes target new mechanisms...